Emgality 120 mg

EMGALITY 120 MG is a subcutaneous solution containing galcanezumab, used for migraine prevention. This prescription medication is designed to reduce the frequency of migraine headaches in adults.

EMGALITY 120 MG is primarily used for migraine prevention. It is a calcitonin gene-related peptide (CGRP) antagonist, which may help in reducing the number of migraine days experienced by adults. This medication is not intended for the acute treatment of migraines but rather for long-term prevention.

Common effects of EMGALITY 120 MG may include injection site reactions such as redness, pain, or swelling. Some users might experience constipation, upper respiratory infections, or fatigue. These effects vary among individuals and are not exhaustive.

EMGALITY 120 MG should be used under medical supervision. It is important to inform your healthcare provider about any allergies or medical conditions before starting this treatment. The solution should be stored properly and administered as directed.

EMGALITY 120 MG may interact with other medications, including those metabolized by certain liver enzymes. It is advisable to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and other substances should be considered carefully.